Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma.
暂无分享,去创建一个
V. Jobanputra | R. Darnell | Anne-Katrin Emde | K. Wrzeszczynski | Vanessa Felice | Minita Shah | Sadia Rahman | Mayu O Frank | V. Felice | Minita J. Shah
[1] Neville E. Sanjana,et al. CRISPR Screens to Discover Functional Noncoding Elements. , 2016, Trends in genetics : TIG.
[2] V. Jobanputra,et al. Abstract 4497: NYGC glioblastoma clinical outcomes pilot study: Discovering therapeutic potential in glioblastoma through integrative genomics , 2016 .
[3] Vladimir Vacic,et al. Conpair: concordance and contamination estimator for matched tumor–normal pairs , 2016, Bioinform..
[4] C. Baker,et al. Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA. , 2016, American journal of human genetics.
[5] Shawn M. Gillespie,et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas , 2015, Nature.
[6] M. Gilbert,et al. Advances in the treatment of newly diagnosed glioblastoma , 2015, BMC Medicine.
[7] Donavan T. Cheng,et al. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials. , 2015, Drug discovery today.
[8] Euiseok J. Kim,et al. Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes. , 2015, Cancer cell.
[9] D. Reardon,et al. Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: A case report , 2015, Oncotarget.
[10] Ole Schulz-Trieglaff,et al. Manta: Rapid detection of structural variants and indels for clinical sequencing applications , 2015, bioRxiv.
[11] Timothy C Ryken,et al. Toward precision medicine in glioblastoma: the promise and the challenges. , 2015, Neuro-oncology.
[12] Obi L. Griffith,et al. Optimizing cancer genome sequencing and analysis. , 2015, Cell systems.
[13] Joshua M. Stuart,et al. Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection , 2015, Nature Methods.
[14] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[15] T. Cloughesy,et al. Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma , 2015, Nature Reviews Cancer.
[16] Joon-Oh Park,et al. Constitutive asymmetric dimerization drives oncogenic activation of epidermal growth factor receptor carboxyl-terminal deletion mutants , 2015, Oncotarget.
[17] Nicolai J. Birkbak,et al. Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] Na Li,et al. Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma , 2015, Science Translational Medicine.
[19] H. Ellis,et al. Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma , 2015, Front. Oncol..
[20] Lei Shang,et al. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants , 2014, Proceedings of the National Academy of Sciences.
[21] S. Antonarakis,et al. Extrachromosomal driver mutations in glioblastoma and low grade glioma , 2014, Nature Communications.
[22] Sohrab P. Shah,et al. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data , 2014, Genome research.
[23] Benjamin M. Good,et al. Organizing knowledge to enable personalization of medicine in cancer , 2014, Genome Biology.
[24] Franziska Michor,et al. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. , 2014, Cancer cell.
[25] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[26] Steven J. M. Jones,et al. Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma , 2014, Science.
[27] S. Nelson,et al. Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA , 2014, Science.
[28] Savita Shrivastava,et al. Validation of a next-generation sequencing assay for clinical molecular oncology. , 2014, The Journal of molecular diagnostics : JMD.
[29] L. Deangelis,et al. Glioblastoma and other malignant gliomas: a clinical review. , 2013, JAMA.
[30] H. Gan,et al. The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered , 2013, The FEBS journal.
[31] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[32] K. Aldape,et al. EGFR and EGFRvIII in glioblastoma: partners in crime. , 2013, Cancer cell.
[33] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[34] S. Gabriel,et al. Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.
[35] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[36] Trevor J Pugh,et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation , 2013, Nucleic acids research.
[37] A. Wilm,et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets , 2012, Nucleic acids research.
[38] Thomas Zichner,et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis , 2012, Bioinform..
[39] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[40] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[41] Martin Vingron,et al. Detecting genomic indel variants with exact breakpoints in single- and paired-end sequencing data using SplazerS , 2012, Bioinform..
[42] Mark D. Johnson,et al. Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion , 2011, Proceedings of the National Academy of Sciences.
[43] Michael C. Rusch,et al. CREST maps somatic structural variation in cancer genomes with base-pair resolution , 2011, Nature Methods.
[44] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[45] C. Perou,et al. Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.
[46] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[47] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[48] R. Wilson,et al. BreakDancer: An algorithm for high resolution mapping of genomic structural variation , 2009, Nature Methods.
[49] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[50] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[51] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[52] S. Gabriel,et al. Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain , 2006, PLoS medicine.
[53] Tracy T Batchelor,et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. , 2006, Cancer research.
[54] C. James,et al. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. , 1990, Proceedings of the National Academy of Sciences of the United States of America.